Investment5 Jun 2026, 02:19 pm
Novelix Pharma to Raise ₹6.84 Cr via Preferential Issue
AI Summary
Novelix Pharmaceuticals Ltd announced its Board of Directors has approved a preferential issue of 12,00,000 equity shares at ₹57 each to non-promoters, aiming to raise ₹6.84 crore. This move is subject to shareholder and regulatory approvals. The funds will be utilized for additional capital raising. The issuance price includes a face value of ₹10 and a premium of ₹47 per share.
Key Highlights
- Board approves preferential issue of 12 lakh equity shares.
- Targeting to raise ₹6.84 crore at ₹57 per share.
- Shares to be issued to non-promoters.
- Subject to EGM and regulatory approvals.
- Funds to be used for additional capital.
Price Impact
More from TRIMURTHI